Conduct↦Monitoring↦Routine Monitoring Visit↦Preparation
What is it? Why is it important?
Routine Monitoring Visit(s) (RMV) are carried out after the Site Initiation Visit (SIV) and until the end of the study, or the end of participant recruitment.
During RMVs, the monitor gains an overview of study progress and site compliance. This is important in order to ensure that:
- The safety, rights, and well-being of study participants are being protected
- The quality and integrity of study data are maintained
- The study is conducted in compliance with the study protocol, applicable Swiss laws (e.g. HRA, ClinO, ClinO-MD, HRO, Data Protection (FADP)) and regulations (e.g. GCP, Declaration of Helsinki, ISO 14155, ISO 20916, ISO 20387)
What do I need to do?
If you are the study monitor, make applicable arrangements to prepare for an upcoming RMV:
- Arrange a date for the RMV with the study site
- Based on the IMP/IMD, provide a list of documents to be reviewed
- Ensure access to electronic records (e.g. study eCRF, ISF, relevant medical records such as the patient file)
- Estimate the time needed to complete your monitoring tasks
- Ensure that all study personnel are available for support during the RMV
Extent of study monitoring during RMVs is determined by the MP.
Request any necessary access to electronic records at the study site ahead of time, because it may take time to arrange required access rights. If local access cannot be granted, obtain applicable Source Data (SD) or any other necessary information in printed form.
More
Where can I get help?
Your local Research Support Centre↧ can assist you with experienced staff regarding this topic
Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch
Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch
Bern, Department of Clinical Research (DCR), dcr.unibe.ch
Geneva, Clinical Research Center (CRC), crc.hug.ch
Lausanne, Clinical Research Center (CRC), chuv.ch
St. Gallen, Clinical Trials Unit (CTU), h-och.ch
Zürich, Clinical Trials Center (CTC), usz.ch
References
ICH GCP E6(R2) – see in particular guidelines
- 4.5 Protocol Compliance
- 5.18 Monitoring activities
- 6.10 Access to source data / documents
ISO 14155 Medical Device – see in particular section (access liable to costs)
- 9.2.4 Monitoring
ISO 20916 – In Vitro Diagnostica (access liable to costs)
ISO 20387 – Biobanking (access liable to costs)
Swiss Law
HRA – see in particular
- Art. 1 Purpose
ClinO – see in particular article
- Art. 5 Good Clinical Practice
ClinO-MD – see in particular
- Art. 3 Applicable provisions
HRO – see in particular
- Art. 2 Applicable provisions